Format
Sort by
Items per page

Send to

Choose Destination

Best matches for anticholinergic agents AND memory AND schizophrenia:

Search results

Items: 1 to 20 of 169

1.

The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia.

Ang MS, Abdul Rashid NA, Lam M, Rapisarda A, Kraus M, Keefe RSE, Lee J.

J Clin Psychopharmacol. 2017 Oct 9. doi: 10.1097/JCP.0000000000000790. [Epub ahead of print]

PMID:
29016375
2.

Increased risk of developing schizophrenia in animals exposed to cigarette smoke during the gestational period.

Zugno AI, Oliveira MB, Mastella GA, Heylmann AS, Canever L, Pacheco FD, Damazio LS, Citadin SA, de Lucca LA, Simões LR, Malgarin F, Budni J, Barichello T, Schuck PF, Quevedo J.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Apr 3;75:199-206. doi: 10.1016/j.pnpbp.2017.02.010. Epub 2017 Feb 14.

PMID:
28229913
3.

Pharmacological characterization of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1H-inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulator.

Ward SE, Beswick P, Calcinaghi N, Dawson LA, Gartlon J, Graziani F, Jones DN, Lacroix L, Selina Mok MH, Oliosi B, Pardoe J, Starr K, Woolley ML, Harries MH.

Br J Pharmacol. 2017 Mar;174(5):370-385. doi: 10.1111/bph.13696. Epub 2017 Jan 31.

PMID:
28009436
4.

The atypical antipsychotic olanzapine disturbs depotentiation by modulating mAChRs and impairs reversal learning.

Song WS, Cha JH, Yoon SH, Cho YS, Park KY, Kim MH.

Neuropharmacology. 2017 Mar 1;114:1-11. doi: 10.1016/j.neuropharm.2016.11.012. Epub 2016 Nov 17.

PMID:
27866902
5.

Shared and divergent neurocognitive impairments in adult patients with schizophrenia and bipolar disorder: Whither the evidence?

Kuswanto C, Chin R, Sum MY, Sengupta S, Fagiolini A, McIntyre RS, Vieta E, Sim K.

Neurosci Biobehav Rev. 2016 Feb;61:66-89. doi: 10.1016/j.neubiorev.2015.12.002. Epub 2015 Dec 12. Review.

PMID:
26691725
6.

Effects of the nicotinic agonist varenicline on the performance of tasks of cognition in aged and middle-aged rhesus and pigtail monkeys.

Terry AV Jr, Plagenhoef M, Callahan PM.

Psychopharmacology (Berl). 2016 Mar;233(5):761-71. doi: 10.1007/s00213-015-4154-0. Epub 2015 Nov 27.

7.

Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.

Kake TR, Garrett N, Te Aonui M.

Aust N Z J Psychiatry. 2016 Jun;50(6):566-76. doi: 10.1177/0004867415607986. Epub 2015 Oct 22.

PMID:
26494850
8.
9.

Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine.

Rajji TK, Mulsant BH, Davies S, Kalache SM, Tsoutsoulas C, Pollock BG, Remington G.

Am J Psychiatry. 2015 Jun;172(6):579-85. doi: 10.1176/appi.ajp.2015.14050673. Epub 2015 Apr 10.

PMID:
25859763
10.

Novel 5-HT5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats.

Yamazaki M, Okabe M, Yamamoto N, Yarimizu J, Harada K.

J Pharmacol Sci. 2015 Mar;127(3):362-9. doi: 10.1016/j.jphs.2015.02.006. Epub 2015 Feb 17.

11.

The modulation of nicotinic acetylcholine receptors on the neuronal network oscillations in rat hippocampal CA3 area.

Wang Y, Wang Z, Wang J, Wang Y, Henderson Z, Wang X, Zhang X, Song J, Lu C.

Sci Rep. 2015 Mar 26;5:9493. doi: 10.1038/srep09493.

12.

Heterogeneity across brain regions and neurotransmitter interactions with nicotinic effects on memory function.

Levin ED, Hall BJ, Rezvani AH.

Curr Top Behav Neurosci. 2015;23:87-101. doi: 10.1007/978-3-319-13665-3_4. Review.

PMID:
25655888
13.

Different pharmacology of N-desmethylclozapine at human and rat M2 and M 4 mAChRs in neocortex.

Gigout S, Wierschke S, Dehnicke C, Deisz RA.

Naunyn Schmiedebergs Arch Pharmacol. 2015 May;388(5):487-96. doi: 10.1007/s00210-014-1080-3. Epub 2015 Jan 16.

PMID:
25592256
14.

The α7 nAChR selective agonists as drug candidates for Alzheimer's disease.

Fan H, Gu R, Wei D.

Adv Exp Med Biol. 2015;827:353-65. doi: 10.1007/978-94-017-9245-5_21.

PMID:
25387975
15.

Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents.

Bubser M, Bridges TM, Dencker D, Gould RW, Grannan M, Noetzel MJ, Lamsal A, Niswender CM, Daniels JS, Poslusney MS, Melancon BJ, Tarr JC, Byers FW, Wess J, Duggan ME, Dunlop J, Wood MW, Brandon NJ, Wood MR, Lindsley CW, Conn PJ, Jones CK.

ACS Chem Neurosci. 2014 Oct 15;5(10):920-42. doi: 10.1021/cn500128b. Epub 2014 Aug 19.

16.

Modulation of neuronal microcircuit activities within the medial prefrontal cortex by mGluR5 positive allosteric modulator.

Pollard M, Bartolome JM, Conn PJ, Steckler T, Shaban H.

J Psychopharmacol. 2014 Oct;28(10):935-46. doi: 10.1177/0269881114542856. Epub 2014 Jul 16.

17.

A touch-screen based paired-associates learning (PAL) task for the rat may provide a translatable pharmacological model of human cognitive impairment.

Talpos JC, Aerts N, Fellini L, Steckler T.

Pharmacol Biochem Behav. 2014 Jul;122:97-106. doi: 10.1016/j.pbb.2014.03.014. Epub 2014 Mar 22.

PMID:
24662914
18.

Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor.

Wu HQ, Okuyama M, Kajii Y, Pocivavsek A, Bruno JP, Schwarcz R.

Schizophr Bull. 2014 Mar;40 Suppl 2:S152-8. doi: 10.1093/schbul/sbt157.

19.

Impaired working memory by repeated neonatal MK-801 treatment is ameliorated by galantamine in adult rats.

Su YA, Huang RH, Wang XD, Li JT, Si TM.

Eur J Pharmacol. 2014 Feb 15;725:32-9. doi: 10.1016/j.ejphar.2014.01.007. Epub 2014 Jan 16.

PMID:
24440172
20.

The novel object recognition test in rodents in relation to cognitive impairment in schizophrenia.

Rajagopal L, Massey BW, Huang M, Oyamada Y, Meltzer HY.

Curr Pharm Des. 2014;20(31):5104-14. Review.

PMID:
24345269

Supplemental Content

Loading ...
Support Center